A pharmacogenetics DNA panel makes it possible to study a patient's personal genetic profile from a blood sample. Based on this, it is easier for the doctor to prescribe the right medication at the right dose. The DNA panel can increase the likelihood of successful treatment while reducing the risk of dangerous side effects or ineffective therapy.
The pharmacogenetics DNA panel includes 29 genes associated with the metabolism of over 200 medications.
Pharmacogenetic testing is particularly valuable for the following types of medication: antidepressants and other psychotropic drugs; painkillers and anti-inflammatory drugs; anticoagulants and blood-thinning agents; antibiotics, antiviral and antifungal drugs; antidiabetic drugs; antihypertensive drugs; cytostatics; proton pump inhibitors (acid-reducing drugs); statins for high cholesterol.
A pharmacogenetic profile does not change — the test results are valid for life.
The test result is returned within 2–3 working weeks as an English-language report. The report includes a list of medications and a classification of recommendations. We recommend consulting your treating physician or family doctor to interpret the results.
No fasting is required before giving a blood sample.